Polycystic kidney disease (PKD) is a genetic condition in which fluid-filled cysts grow throughout the kidneys, gradually enlarging them and damaging healthy tissue. It affects roughly 1 in every 400 to 1,000 people and is one of the leading inherited causes of kidney failure. There are two types, but the vast majority of cases follow one pattern: slow progression over decades, with symptoms typically appearing in a person’s 30s or 40s.
The Two Types of PKD
The more common form, autosomal dominant PKD (ADPKD), requires only one parent to carry the gene. If a parent has it, each child has a 50 percent chance of inheriting it. Symptoms usually surface in adulthood, though cysts can sometimes be detected in childhood or even before birth. Up to 50 percent of people with ADPKD need dialysis or a kidney transplant by age 60.
The rarer form, autosomal recessive PKD (ARPKD), requires both parents to carry the mutation. Each child of two carriers has a 25 percent chance of developing the disease. ARPKD typically appears during infancy or childhood and tends to be more severe early in life.
What Causes Cyst Growth
In ADPKD, researchers have identified at least nine genes that can trigger the disease, but two matter most. The first, PKD1, produces a protein that helps kidney tubules sense the flow of urine and maintain their shape. The second, PKD2, produces a protein that works as a calcium channel alongside the first. When either protein malfunctions, kidney tubules lose their structural discipline, dilate, and balloon into cysts that fill with fluid.
Which gene is affected makes a real difference in how quickly the disease progresses. People with PKD1 mutations generally face more aggressive disease, with a median age of needing dialysis or transplant around 56 years. Those with PKD2 mutations follow a slower course, with that milestone pushed to around 68 years. Knowing the specific mutation helps doctors estimate what lies ahead.
Symptoms and What They Feel Like
Early on, PKD often causes no noticeable symptoms. As cysts multiply and the kidneys enlarge, the most common complaints are a dull ache or feeling of fullness in the back or sides, high blood pressure, and blood in the urine. Some people notice frequent urinary tract infections or kidney stones. Because the kidneys can grow substantially (sometimes to the size of a football), abdominal bloating and early fullness after eating are common in later stages.
High blood pressure is often one of the earliest signs and can appear years before kidney function starts to decline. It develops because enlarged cysts compress blood vessels within the kidney, triggering hormonal signals that raise pressure throughout the body.
Problems Beyond the Kidneys
PKD is not strictly a kidney disease. The same genetic defect affects other organs, and being aware of these complications matters for long-term health.
- Liver cysts are the most common extra-kidney finding. Ultrasound detects them in 10 to 20 percent of people under 30, rising to 50 to 70 percent over age 60. MRI, which catches smaller cysts, finds them in roughly 83 percent of younger adults. Women, especially those who have had multiple pregnancies, are more likely to develop large liver cysts, though these rarely cause liver failure.
- Brain aneurysms occur at four times the rate seen in the general population, affecting 8 to 12 percent of people with ADPKD compared with 2 to 3 percent of everyone else. About half of those found to have a brain aneurysm still have normal kidney function at the time of discovery, so this risk exists independent of how advanced the kidney disease is. The middle cerebral artery is the most commonly affected location, and nearly a third of patients have more than one aneurysm.
- Heart valve abnormalities, pancreatic cysts, and hernias also occur more frequently in PKD, though they tend to cause fewer day-to-day problems.
How PKD Is Diagnosed
For someone with a family history of PKD, an ultrasound is usually the first test. The diagnostic bar depends on age. In people under 30, finding at least two cysts in one or both kidneys is enough to confirm the diagnosis. Between ages 30 and 59, doctors look for at least two cysts in each kidney. After 60, at least four cysts in each kidney are needed, because simple cysts become common with aging and the threshold must be higher to avoid false positives.
Genetic testing can confirm the diagnosis when imaging is inconclusive, and it identifies which gene is responsible. This is particularly useful for younger adults who want to understand their likely disease course or who are considering having children.
Tracking Disease Progression
Kidney size turns out to be one of the most reliable predictors of future decline. Total kidney volume, measured by MRI, is now recognized by the FDA as a prognostic biomarker. Doctors combine kidney volume with a patient’s age and current kidney function to estimate whether the disease is progressing slowly, moderately, or rapidly. A total kidney volume of one liter or more signals relatively higher risk. This classification helps determine who might benefit most from treatment and how closely kidney function should be monitored.
Treatment That Slows Progression
There is currently one FDA-approved medication specifically for ADPKD. It works by blocking a hormone receptor (vasopressin V2) involved in cyst growth, slowing the rate at which kidney function declines. It is indicated for adults at risk of rapidly progressing disease. Because the drug can cause liver injury, patients undergo regular liver blood tests: every two weeks and then monthly for the first 18 months, then every three months after that. Treatment is stopped immediately if liver enzymes rise above certain thresholds.
The medication also causes significant thirst and frequent urination, since blocking vasopressin reduces the kidney’s ability to concentrate urine. These side effects are manageable for most people but can be disruptive enough that some choose to discontinue treatment.
Diet and Lifestyle Strategies
Dietary changes can meaningfully slow disease progression alongside medication. Sodium is the single most impactful target. Keeping intake at or below 2,300 milligrams per day helps lower blood pressure and reduces the rate of cyst growth. For context, a single fast-food meal can contain more than an entire day’s allowance.
Protein intake also matters. The recommended range is 0.8 to 1 gram of protein per kilogram of body weight daily. Diets exceeding 1.3 grams per kilogram may be harmful. Plant-based proteins from beans, grains, and nuts appear to be gentler on the kidneys than animal-based proteins, which raise urinary acid levels and may accelerate cyst growth.
Water intake plays a surprisingly direct role. Drinking at least 3 quarts daily (about 12 eight-ounce glasses) helps suppress vasopressin, the same hormone targeted by medication. Vasopressin stimulates cyst growth, so keeping it low through steady hydration throughout the day works as a simple, drug-free way to slow the disease. Drinking most of your water in one sitting is less effective than spacing it evenly from morning through evening.
Beyond diet, managing blood pressure early and consistently is one of the most important things you can do. Regular exercise, maintaining a healthy weight, and working with your doctor to keep blood pressure well controlled all contribute to preserving kidney function for as long as possible.